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Background: IRAK-M is an inhibitor of Toll-like receptor signaling that acts by re-directing IRAK-4 activity to TAK1
independent NF-κB activation and by inhibition of IRAK-1/IRAK-2 activity. IRAK-M is expressed in monocytes/macrophages
and lung epithelial cells. Lack of IRAK-M in mice greatly improves the resistance to nosocomial pneumonia and lung
tumors, which entices IRAK-M as a potential therapeutic target. IRAK-M consists of an N-terminal death domain (DD), a
dysfunctional kinase domain and unstructured C-terminal domain. Little is known however on IRAK-M’s structure-function
relationships.
Results: Since death domains provide the important interactions of IRAK-1, IRAK-2 and IRAK-4 molecules, we
generated a 3D structure model of the human IRAK-M-DD (residues C5-G119) to guide mutagenesis studies and
predict protein-protein interaction points. First we identified the DD residues involved in the endogenous capacity of
IRAK-M to activate NF-κB that is displayed upon overexpression in 293T cells. W74 and R97, at distinct interfaces of the
IRAK-M-DD, were crucial for this endogenous NF-κB activating capacity, as well as the C-terminal domain (S445-E596)
of IRAK-M. Resulting anti-inflammatory A20 and pro-inflammatory IL-8 transcription in 293T cells was W74 dependent,
while IL-8 protein expression was dependent on R97 and the TRAF6 binding motif at P478. The IRAK-M-DD W74 and
R97 binding interfaces are predicted to interact with opposite sides of IRAK-4-DD’s. Secondly we identified DD residues
important for the inhibitory action of IRAK-M by stable overexpression of mutants in THP-1 macrophages and H292
lung epithelial cells. IRAK-M inhibited TLR2/4-mediated cytokine production in macrophages in a manner that is largely
dependent on W74. R97 was not involved in inhibition of TNF production but was engaged in IL-6 down-regulation by
IRAK-M. Protein-interactive residues D19-A23, located in between W74 and R97, were also observed to be crucial for
inhibition of TLR2/4 mediated cytokine induction in macrophages. Remarkably, IRAK-M inhibited TLR5 mediated IL-8
production by lung epithelial cells independent of W74 and R97, but dependent on D19-A23 and R70, two
surface-exposed regions that harbor predicted IRAK-2-DD interaction points of IRAK-M.
Conclusion: IRAK-M employs alternate residues of its DD to inhibit the different inflammatory mediators induced by
varying TLRs and cells.
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Interleukin-1 receptor-associated kinase M (IRAK-M) is a
member of the IRAK protein family [1], a family of proteins
that is crucially involved in signaling initiated by the cyto-
kines IL-1 and IL-18 and in Toll-like receptor activation
[2]. Activation of the receptors leads to dimerization of the
adaptor protein MyD88, and subsequent recruitment of* Correspondence: c.vantveer@amc.uva.nl
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unless otherwise stated.IRAK-4 and other IRAK’s to form multimers (myddo-
somes) by homo- and heteromeric interactions of the death
domains present in these IRAK’s [3,4]. Binding and phos-
phorylation events triggered by IRAK-4 result in hyper-
and auto-phosphorylation of IRAK-1 and formation of
IRAK-1/TRAF-6 complexes which dissociate from the
receptor to activate TAB2/3 and TAK-1 [5]. TAB/TAK/
TRAF6 activity leads to IκBα phosphorylation and ubiquiti-
nation, culminating in nuclear factor-κB (NF-κB) activation
and transcription of inflammatory genes [5]. IRAK-2 hyper-
phosphorylation and TAB/TAK/TRAF6 activity leads to
specific IRAK-2 dependent mRNA stabilization andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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All IRAK family members mediate activation of NF-κB and
MAPK [1] and the phenotype of IRAK-1, IRAK-2 and
IRAK-4 deficient mice or cells is one of decreased produc-
tion of inflammatory mediators [5]. In contrast, IRAK-M
deficient mice or cells display an increased inflammatory
response [9], illustrating the essentially different function of
IRAK-M.
Structurally, IRAK-M consists of a kinase domain (KD)
flanked by an N-terminal death domain (DD) involved in
binding to other IRAK family members and an unstruc-
tured C-terminal domain (CTD) with a TRAF6 binding
motif [1,10]. IRAK-1 and IRAK-4 contain active kinase
domains, but IRAK-M and IRAK-2 lack the critical active
site aspartate residue and appear devoid of kinase activity
[1,10]. It has been reported that IRAK-M inhibits IRAK
signaling by binding to the IRAK-1/IRAK-4 dimer assem-
bled on the receptor-bound MyD88, thereby preventing
IRAK-1/TRAF6 downstream signaling [9]. However, also
other mechanisms have been put forward by which IRAK-
M may inhibit inflammation in a more active manner,
such as through IRAK-M dependent stabilization of
MKP-1 [11] and down-regulation of the non-canonical
NF-κB pathway [12]. Only recently it was shown that
murine IRAK-M is redundant with IRAK-1/2 with respect
to NF-κB activation through a unique IRAK-4/IRAK-M
mediated MEKK3 pathway [13]. This pathway specifically
induces IRAK-M dependent transcription of negative
regulators such as A20, IκBα, SOCS-1 and SHIP [13]. Fur-
thermore, IRAK-M was shown to inhibit the IRAK-2
dependent mRNA stabilization/translation of cytokines
and chemokines [13]. Increased host responses caused by
lack of IRAK-M are favorable for the clinical outcome in
bacterial pneumonia [14-16], but also in tumor models
[17] and bone marrow transplantation [18] which implies
that inhibition of IRAK-M might have therapeutic poten-
tial. Different from the other IRAK’s, IRAK-M expression
is rather restricted to certain cell types such as mono-
cytes/macrophages and lung epithelial cells [1,19] and
IRAK-M is up-regulated under inflammatory conditions
and associated with LPS tolerance [9,20].
Zhou et al. [13] showed that the conserved W74 residue
in the DD of murine IRAK-M was crucial for the inter-
action with IRAK-4 and NF-κB activation. Here we show
that both the DD as well as the CTD of IRAK-M are
important for the endogenous NF-κB activation capacity
of human IRAK-M upon overexpression in 293T cells. We
investigated the structure-function relationships of the
human IRAK-M DD by mutagenesis of predicted protein
interaction sites. We identified at least 3 sites on the DD
of IRAK-M which are involved in IRAK-M’s function.
Two of these, located on opposite sides of the death
domain and constellated by W74/Q78/F18 and R97/Y105
respectively, are predicted to interact with different sidesof the IRAK-4 DD. Both sites and the interactive area in
between these sites formed by the surfacing stretch D19
to A23 were observed to be involved in the capacity of
IRAK-M to inhibit TLR mediated cytokine production in
human macrophages. Thus, we identified and character-
ized the primary interactive sites on the DD of IRAK-M
on the basis of a structural model.
Results
Homology model of the human IRAK-M death domain
We generated a model for the death domain (DD) of
human IRAK-M (IRAK-M-DD) by homology modeling
based on the crystal structure of the DD of mouse IRAK-4
(PDB 2A9I [21], which has 28.7% sequence identity to the
human IRAK-M DD as described in the Methods section).
The generated IRAK-M-DD structure (Figure 1A) with 6
helical bundles forms a hydrophobic core that is decorated
with a charged outer layer. An anti-parallel beta sheet, not
seen in the template structure is formed by one strand
from the N-terminus and another strand N-terminal of
helix 5. An anti-parallel sheet located in between helix2
and helix3 of the template structure is absent in the DD of
IRAK-M, instead a beta turn is made here by two serine
residues in our model. Unconstrained molecular dynamics
simulation for 100 nanoseconds (ns) indicated good stabil-
ity of this structure (Additional file 1: Figure S1) and the
quality of the structure was further verified by means of
the total energy, root mean square deviation (RMSD) and
the number of hydrogen bonds in the DD domain.
Residues predicted to be involved in protein-protein
interactions were identified as described in the Methods
section. The identified potential interactive residues are
present in areas formed by the N-terminus of helix1, the
C-terminus of helix4, the loop between helix4 and helix5,
and helix6 (Figure 1B and C).
Functional analysis of DD mutagenesis after transient
overexpression of IRAK-M variants in 293T cells
Based on our IRAK-M-DD model we probed potential
interactive residues via structurally conservative muta-
genesis of full-length human IRAK-M (Additional file 2:
Table S1). The selected residues for mutation we predicted
to be surface exposed and do not form intra-molecular
contacts (see Figure 1C). In the binding area formed by
helix1/helix4+loop we constructed a F18A mutant, gener-
ated a combined D19N-L20A-P21A mutant and a com-
bined P22A-A23S mutant, and R70Q, W74A and Q78A
single mutant molecules. We verified that all mutants were
expressed in 293T cells at comparable levels by evaluation
of expression levels with an antibody against the C-
terminus of IRAK-M (Figure 2A). Overexpression of IRAK-
M in 293T cells results in endogenous IRAK signaling. No
major alterations were observed in the levels of the
endogenous IRAK signaling pathway upon transfection of
Figure 1 3D structure model of the human IRAK-M death domain (DD). (A) Model of the DD of human IRAK-M (Blue) superimposed on the
template DD structure 2A9I (Orange) of mIRAK-4 and sequence alignment of hIRAK-M-DD and mIRAK-4-DD. The sequence identity is 28.7%. Secondary
structures such as alpha-helices and beta-strands of mIRAK-4-DD (2A9I) are indicated underneath the sequences (Red bar: alpha-helix: Purple bar: unstable
helix; Green arrow: beta-strand). (B) Interactive surface prediction of hIRAK-M-DD. Space filling model with predicted interactive residues in red that
form two patches. (C) The predicted interactive residues in the two patches which were mutated in this study are shown with side chain and residue
number in the back bone model in red and blue.
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determined the capacity of these human IRAK-M variants
to activate NF-κB spontaneously when overexpressed in
293T cells as had been described for WT IRAK-M [1]. As
shown in Figure 2B, human WT IRAK-M induces NF-κB
in 293T cells, this function is fully dependent on the death
domain since deletion of the death domain reduced this
capacity to control level. Mutation of only F18 or D19-P21
only moderately affected the capacity of IRAK-M to induce
NF-κB activity. Mutation of P22-A23 and Q78 caused a
marked reduction in NF-κB. Single mutation of W74 com-
pletely abolished the capacity of IRAK-M to induce NF-κB
in agreement with the study of Zhou et al. [13] of murine
IRAK-M. Combined mutation of F18/D19-P21 did not re-
sult in a further reduction of NF-κB compared to the single
mutants (Figure 2B). Notably, the combined mutation of
D19-P21/P22-A23 resulted in a mutant that regained its
full NF-κB activating capacity as compared to the P22-A23
mutant, which indicates that the D19-A23 stretch mayharbor a negative control element. R70 mutation did not
affect NF-κB activity. Combined mutation of F18/Q78, ad-
jacent residues in the 3D structure, resulted in a mutant
that fully lost its NF-κB activating capacity (Figure 2B).
Thus it seems that W74 and F18/Q78 interactions are piv-
otal in the spontaneous NF-κB activating capacity of
IRAK-M in 293T cells and that the D19-A23 stretch has
only a regulatory role in this.
Mutation of R97 and Y105 in the interactive area of
helix6, revealed that also R97 is of major importance in
the NF-κB activating activity of IRAK-M in 293T cells
while single mutation at Y105 exerts only a modest effect
on NF-κB (Figure 2B). However, combined R97/Y105
mutation reduced NF-κB to the level of the death domain
deletion mutant which identifies these residues as a sec-
ond crucial binding site for the NF-κB activating activity
of IRAK-M in 293T cells (Figure 2B).
IRAK-M has been reported to induce transcription of









































































































































































































































































































Figure 2 Expression and functional analysis of human IRAK-M-DD mutants in 293T cells. (A) Analysis of expression levels of IRAK-M variants
by transfection in 293T cells by Western blotting performed on cell lysates with an antibody directed to the C-terminal of IRAK-M. (B) Effect of
IRAK-M-DD mutations on NF-κB activation by overexpression in 293T cells. (C) Effect of IRAK-M-DD mutations on A20 mRNA induction by overexpression
in 293T cells. (D) Effect of IRAK-M-DD mutations on IL-8 protein and mRNA production by overexpression in 293T cells. (B-D) N=4, mean±SEM. *Indicates
difference with WT IRAK-M P<0.05. Shaded bars depict results of IRAK-M molecules with combinations of mutated residues/stretches within the
same patch.
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tion was induced by IRAK-M in 293T cells in a manner
that appears primarily dependent on W74 (Figure 2C).
Although R97 was involved in over 80% of the induced
NF-κB (Figure 2B), the R97Q mutant generated the full
A20 transcript potential. Importantly, while single muta-
tion of R97 and Y105 did not impact on A20 transcript
levels the R97Q/Y105A double mutant displayed signifi-
cantly reduced levels of A20 mRNA, indicating a partial
role of these helix 6 residues in A20 transcript expression.
Overexpression of IRAK-M in 293T cells also induced
IL-8 secretion which involves NF-κB dependent transcrip-
tion and translation [22]. The IL-8 production induced bythe different DD-mutants in 293T cells (Figure 2D) oc-
curred analogous to the NF-κB activity (Figure 2B). In line
with the reduced NF-κB and IL-8 protein production cap-
acity of the helix 1/4-5 mutants W74A, P22A-A23S and
F18A/Q78A, the IL-8 transcript levels induced by these
mutants were markedly reduced indicating pivotal in-
volvement of these adjacent residues in transcription. In
contrast IL-8 transcript production was not affected by
mutation of R97, while IL-8 protein production by the
R97Q mutant was 85% reduced (Figure 2D) indicating a
role for this site in helix 6 in translation by a different
pathway. Combined mutation of R97 and Y105 resulted in
decreased IL-8 transcript levels (Figure 2D), but the
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Y105A mutation was importantly larger than that of the
helix 1 mutants F18A and P22A-A23S with similar tran-
script levels (Figure 2D). The latter also points to involve-
ment of the binding site in helix 6 of IRAK-M in protein
translation. Remarkably, the R70Q mutant displayed
significant hyperactivity with regard to IL-8 transcription
and translation compared to WT IRAK-M. The combined
D19-P21/P22-A23 mutant induced IL-8 protein and tran-
script levels equally well as WT IRAK-M.
Functional analysis of C-terminal domain mutants after
transient overexpression of IRAK-M variants in 293T cells
IRAK-M dependent NF-κB activation proceeds in IRAK-
1/IRAK2 double deficient cells through a unique MEKK3
pathway [13]. Taking this into account it can be hypothe-
sized that IRAK-4/IRAK-M complexes recruit MEKK3
and activate TRAF6 in a specific manner that is dependent
on a putative TRAF6 binding motif in the IRAK-M C-
terminal domain (CTD) that extends from the inactive
kinase domain. Because no experimental data existed yet
on the functional involvement of the CTD (amino acid
S445-E596) of IRAK-M, we generated an IRAK-M variant
truncated at position S445 that lacks the entire CTD
(CTD-Δ). Furthermore we mutated the P478VEDDE483
TRAF6 binding motif [10] in the CTD by introduction of
a P478G substitution and generated a mutant that lacks
the C-terminal part of the CTD by truncation at position
K526. The P478G mutant was expressed similar as WT
IRAK-M, and, as anticipated, the CTD deletion and K526
truncation mutant were not recognized by antibodies di-
rected against the C-terminus of IRAK-M (Figure 2A). A
polyclonal antibody raised against full-length IRAK-M dis-
played the expression of these CTD mutants (Figure 3A).
Deletion of the complete CTD resulted in a major reduc-
tion of the NF-κB activating capacity of IRAK-M when
overexpressed in 293T cells, while the P478G mutation in
the TRAF6 binding motif led to a non-significant reduc-
tion in NF-κB (Figure 3B). Truncation of the CTD at
position K526 did not affect NF-κB activity. Together
these data indicate a major involvement of the CTD in the
NF-κB activating capacity of IRAK-M, which appears
independent of the TRAF6 binding motif at P478.
Deletion of the CTD of IRAK-M resulted in a partial
reduction of the A20 mRNA levels induced by IRAK-M.
The TRAF6 binding site at P478 was not involved in the
expression of A20 transcripts (Figure 3C). Remarkably,
truncation of the IRAK-M CTD at K526 somewhat poten-
tiated A20 transcript levels in 293T cells.
The reduced capacity of the IRAK-M CTD-Δ mutant to
activate NF-κB was associated with an almost complete
loss of IL-8 production (Figure 3D). Interestingly, the
TRAF6 binding motif at P478 appeared essential for IL-8
production by IRAK-M, this while NF-κB was hardlyaffected by the P478G substitution (Figure 3B and D). For
comparison the DD-mutants D19-A21 and P22A-A23S
mutant were studied simultaneously. These mutants dis-
played NF-κB levels comparable to the P478G mutant and
CTD-Δ mutant, however the CTD mutants displayed a
much larger effect on IL-8 protein production compared
to these DD-mutants. NF-κB, IL-8 transcription and
translation correlated well for the D19-A21 and P22A-
A23S mutants. The TRAF6 binding site mutant P478G
however induced IL-8 transcripts as efficient as WT
IRAK-M, while IL-8 protein levels induced by this mutant
are 80% reduced (Figure 3D) which indicates involvement
of the TRAF6 binding site in IL-8 translation upon trans-
fection of IRAK-M in 293T cells. IL-8 transcription was
induced by the CTD-Δ mutant (Figure 3D) albeit at a
lower level than was observed for WT IRAK-M, which
may indicate a role for the CTD in IL-8 transcription or
mRNA stabilization in 293T cells. Truncation of the CTD
of IRAK-M at position 526 did not significantly affect IL-8
transcript levels or protein expression.
Modeling of putative IRAK-M-DD tetramer and protein
docking in the myddosome structure
Our structural model for the DD of IRAK-M appeared a
reliable tool to guide our mutagenesis experiments. This
prompted us to use the model in protein docking simula-
tion experiments. The DDs of IRAK-4 and IRAK-2 form
homotetramers in the myddosome structure [3] and we
could superimpose four of our IRAK-M-DD model struc-
tures in either the coordinates of the IRAK-4 or IRAK-2
tetramer of the reported myddosome structure (3MOP,
[3]) as depicted in Additional file 1: Figure S3A. Figure
S3B in Additional file 1 shows the predicted IRAK-M-DD
interactions involved in the formation of IRAK-M-DD
homotetramers which include F18, P22, A23, L25, G65
and R70 of one DD and L53, K60 and Q64 of another
IRAK-M-DD. The observation that both W74 and R97
are pivotal for the IRAK-M activity towards NF-κB and
the notion that IRAK-M mediated NF-κB is IRAK-4
dependent [13] prompted us to model the interaction of
the IRAK-M-DD tetramer structure with the IRAK-4-DD
tetramer derived from the earlier experimentally deter-
mined myddosome structure, deposited as the 3MOP.pdb
structure. In the 3MOP structure, a tetramer of IRAK-4-
DD’s interacts with a tetramer of the DD’s of MyD88 on
one side, and a tetramer of IRAK-2-DD’s on the other
side. Unbiased in silico protein docking of the IRAK-M-
DD tetramer onto the IRAK-4-DD tetramer side which in-
teracts with IRAK-2 in 3MOP displays a W74 dependent
interaction of IRAK-M with IRAK-4 (Figure 4A) in ac-
cordance with the reported W74 importance for IRAK-4
binding [13]. However no contact point is predicted for
R97 in this type of interaction given that R97 is in fact lo-


































































































































































































































Figure 3 Expression and functional analysis of IRAK-M C-terminal domain mutants in 293T cells. (A) Analysis of transient expression of
IRAK-M and C-terminal domain mutants by transfection in 293T cells by Western blotting performed on cell lysates with an antibody directed to
full length IRAK-M. (B) Effect of IRAK-M C-terminal domain mutation on NF-κB activation by overexpression in 293T cells. (C) Effect of IRAK-M
C-terminal domain mutation on A20 mRNA induction by overexpressing in 293T cells. (D) Effect of IRAK-M C-terminal domain mutation on IL-8
protein and mRNA production by overexpression in 293T cells. (B-D) Comparison to IRAK-M-DD mutants in the D19-A23 stretch. N=4, mean±SEM.
*Indicates difference with WT IRAK-M P<0.05.
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Figure 4 Protein:protein docking of IRAK-M-DD tetramers onto IRAK-4-DD tetramers or IRAK-2-DD tetramers. (A) IRAK-M-DD interactions
predicted to be important for the contact between IRAK-M and IRAK-4 as obtained by unbiased docking of the IRAK-M tetramer (Yellow) onto
the bottom surface of the IRAK-4 tetramer structure (Purple) as is present in the myddosome (3MOP.pdb also F). The residues involved in the
interaction are shown with their side chains, of which the residues from IRAK-M are labeled with their respective residue name and number. Two
interaction types were involved (type I residues L20, P21, P22, A23, R70, type II residues L16, F18, W74, S75, Q78). This orientation was observed
for 63% of the 100 best docked events. (B) IRAK-M-DD interactions predicted to be important for the contact between IRAK-M and IRAK-4 as
obtained by unbiased docking of the IRAK-M tetramer (Yellow) on the top surface of IRAK-4 tetramer (Purple). The residues involved in the
interaction are shown with their side chains, including R97. This orientation was observed for 37% of the 100 best docked events. (C) Potential
sandwich of one IRAK-4-DD tetramer in between 2 IRAK-M-DD tetramers by W74 and R97 mediated interactions. The respective predicted IRAK-4
interactions are shown in detail. (D) Docking of mutant IRAK-M-DD predicts increased IRAK-4 interaction with the IRAK-M R70Q mutant through
an extra hydrogen bond formed between Q70 in IRAK-M and R54 in IRAK-4. (E) Part of the composite binding site of the free side of the IRAK-2-DD
tetramer in the myddosome is shown with three IRAK-M-DD molecules. The contact residues are shown with their side chain. The residues involved in
the interaction from IRAK-M are labeled. Three interaction types were involved. F) A proposed whole myddosome structure with IRAK-M-DD tetramer
docked on the free side of the IRAK-2-DD tetramer, based on the myddosome structure, 3MOP.pdb.
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IRAK-M-DD tetramer was docked unbiased at the top
side of the IRAK-4 tetramer (Figure 4B) there were sig-
nificant contacts noted with R97 interacting with
IRAK-4 residues W74, T77, C79 and D83 (Figure 4C2).
When IRAK-M tetramers were docked onto IRAK-4 tet-
ramers completely without any restrictions, we observed
two different overall docking poses: 63% of the binding
events were with the W74 exposing side and 37% with the
R97 side. Our results indicate that IRAK-M may actually
have the capacity to bind, oligomerize and activate IRAK-
4 in a MyD88 type of manner to induce NF-κB, transcrip-
tion and translation via respectively IRAK-1 and IRAK-2.
Furthermore, there is also the possibility that one IRAK-4
tetramer may actually form a complex with two IRAK-M
tetramers on either side as depicted in Figure 4C1.
We observed that the IRAK-M-DD R70Q variant displays
hyper-reactivity towards IL-8 production when expressed in
293T cells (Figure 2D). Structure analysis of the DD-model
indicated that the R70Q variant may actually form an extra
hydrogen bond with R54 of IRAK-4 (Figure 4D). Remark-
ably, the extra interaction with IRAK-4 of R70Q led to in-
creased transcript and protein levels of IL-8 without an
increase in total NF-κB (Figure 2B,D).
Unbiased docking of the IRAK-M-DD tetramer to the
free side of the IRAK-2-DD tetramer in 3MOP (see
Figure 4F) indicated the W74 side to be plausibly involved
in protein-protein contacts (Figure 4E) without involvement
of R97. R70 is predicted to be involved in the interaction
with IRAK-2 (Figure 4E), but different from the interaction
gain with IRAK-4, the R70Q mutant is predicted to lose the
IRAK-2 interaction points at position 70 of IRAK-M.
Potency of IRAK-M-DD mutants to inhibit TLR signaling in
macrophages
IRAK-M is expressed in monocytes/macrophages and in
lung epithelial cells and IRAK-M is an important factor to
down-regulate host defense in bacterial pneumonia
models [1,14-16,19]. In order to study the potential pro-
and anti-inflammatory effects of human WT IRAK-M and
the DD mutants on TLR mediated cytokine/chemokine
release we stably introduced these proteins in human
monocytic cells (THP-1) and in human bronchial lung
epithelial cells (H292). Coding sequences of WT and mu-
tant IRAK-M were stably introduced by a lentiviral system
with bicistronic expression of eGFP that enabled FACS-
sorting of eGFP positive cells such as to obtain IRAK-M
expressing cells of identical and homogeneous transcrip-
tion for WT and mutant transgenes. Most mutants
showed comparable or somewhat higher protein levels
than WT IRAK-M upon stable expression in THP-1 and
H292 cells (Figures 5A and 6A), however the hyperactive
mutant R70Q displayed lower expression, and the D19N-
A23S mutant displayed markedly lower steady stateprotein levels. Identical levels of IRAK-M mRNA were ob-
served for the R70Q and D19N-A23S mutants as for WT
IRAK-M (Additional file 1: Figure S4A), and since all mu-
tants showed similar protein expression upon transient
expression in 293T cells (Figure 2A) it appears that the
R70Q and D19N-A23S mutants are prone to increased
protein turnover in a more proficient cell type. Inhibition
studies with proteasome inhibitor MG-132 or an IRAK-1/
4 inhibitor did not normalize expression of these mutants.
Thus the mechanism underlying the high turnover and/or
low protein expression level of these mutants remains
elusive, although it may correlate with their relatively high
activity.
Overexpression of WT IRAK-M in human THP-1 de-
rived macrophages significantly inhibited TLR2 and TLR4
induced TNF and IL-6 production in a death domain
dependent manner (Figure 5B). Mutation of the residues
D19-P21, P22-A23, W74 and Q78 resulted in partially or
completely restored TNF and IL-6 production in macro-
phages (Figure 5B). In contrast, single or combined muta-
tion of R97 and Y105 in helix 6 did not or hardly
influence TNF production induced by respectively TLR2
or TLR4 when compared to WT IRAK-M (Figure 5B).
Single R97Q mutation even resulted in increased capacity
of IRAK-M to inhibit Pam3CSK4 induced TNF produc-
tion, when compared to WT IRAK-M . Pam3CSK4
induced IL-6 release was however partially restored by
R97 and Y105 mutation and more so in case of the R97Q/
Y105A double mutant. Remarkably, mutation of R97 and
combined R97/Y105 mutation reduced the capacity of
IRAK-M to inhibit LPS induced IL-6 production consider-
ably and the helix 6 interaction appeared equally im-
portant for inhibition of LPS induced IL-6 by IRAK-M
as the D19-P21, P22-A23 and W74 type of interactions
(Figure 5B). Although the steady state expression level of
the D19-A23 mutant is low in macrophages (Figure 5A)
this mutant still reduced LPS mediated TNF and IL-6
production significantly compared to the eGFP-control
(Figure 5B). These results indicate that IRAK-M inhibits
cytokine production in macrophages with a dominant role
for W74 and surrounding residues in controlling TNF
production, and a differential role for the helix 6 residues
R97 and Y105 which appear to control LPS mediated IL-6
by IRAK-M in cooperation with residues on the other side
of the putative IRAK-M tetramer.
Potency of IRAK-M-DD mutants to inhibit TLR5 and IL-1β
signaling in lung epithelial cells
IRAK-M has been reported to be expressed in lung
epithelial cells [19]. Lung epithelial cells are relatively
unresponsive to TLR2 and TLR4 agonist, but react potently
to MyD88/IRAK dependent IL-1 receptor and TLR5 stimu-
lation [23], which we could confirm with the lung epithelial





























































































































































































































































































































































































































































































Figure 5 (See legend on next page.)
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Figure 5 Effect of human IRAK-M and death domain mutants in macrophages. WT IRAK-M and DD-mutants were stably expressed in the
human monocytic cell line THP-1 by lentiviral transduction and FACS-sorting of EGFP positive cells which is bicistronically expressed. THP-1 cells
were matured to macrophages before stimulation as described in Methods. (A) IRAK-M expression evaluated by western blotting. (B) The effect
of stable WT IRAK-M expression and IRAK-M mutants was determined on TLR2 (Pam3CSK4) and TLR4 (LPS) mediated TNF and IL-6 production
after stimulation for 6 hour. Shaded bars depict results of IRAK-M molecules with combinations of mutated residues/stretches within the same
area. N=4, mean±SEM. *Indicates a difference with WT IRAK-M P<0.05.
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lin derived from the flagella of certain Gram-negative bac-
teria such as P. aeruginosa. In this respect it is noteworthy
that IRAK-M−/− mice are protected from P. aeruginosa
pneumonia under immunocompromised conditions caused
by cecal ligation and puncture [14]. TLR5 mediated IL-8
production by H292 lung epithelial cells after Flagellin
stimulation was significantly inhibited by WT IRAK-M
(Figure 6B). The inhibition of TLR5 mediated IL-8 produc-
tion by IRAK-M was completely death domain dependent
since the DD-deletion mutant showed no effect on IL-8
production. The R70Q mutation was associated with par-
tially restored IL-8 production. Mutagenesis of the D19-
A23 stretch resulted in complete restoration of chemokine
production. Interestingly mutation of key residue W74 did
not influence the inhibitory effect exerted by IRAK-M on
TLR5 mediated IL-8 production. Remarkably R97 and
Y105 mutagenesis prominently enforced the inhibitory cap-
acity of IRAK-M to inhibit TLR5 mediated IL-8 production
(Figure 6B), an effect that was also observed for some other
mutants (P22A-A23S and Q78A). The inhibitory action of
IRAK-M and mutants on Flagellin induced IL-8 release was
in line with the level of induced IL-8 transcripts indicating
an inhibitory control in this setting by IRAK-M on IL-8
transcription and/or transcript stabilization (Figure 6C).
In contrast to the inhibition of TLR5 stimulated IL-8
expression, the IL-1β stimulated IL-8 expression by H292
lung epithelial cells was enhanced by WT IRAK-M
(Figure 6B). The latter is however consistent with the
notion that IRAK-M may substitute for IRAK-1 in IL-1β
signaling [1]. Most DD-mutants did not show this stimu-
latory effect, interestingly however the DD-deletion mu-
tant which lacks the entire DD also displayed some
unexplained stimulation of IL-1β driven IL-8 expression.
To evaluate whether the dampening of TLR5 mediated
IL-8 production by IRAK-M was caused by increased
mRNA expression of negative feedback inhibitors such as
A20 [13] we determined A20, SHIP-1 and SOCS-3 tran-
script levels in H292 cells that overexpressed WT or mu-
tant IRAK-M proteins after 3 hours of stimulation.
Instead of inducing A20 levels, IRAK-M appeared to
inhibit Flagellin induced A20 and SOCS-3 expression in
H292 cells (Additional file 1: Figure S5), and while IRAK-
M seemed to up regulate basal SHIP-1 levels, this effect
however appeared to be retained by the DD-deletion mu-
tant that did not inhibit IL-8 release. Thus, our resultssuggest that IRAK-M regulates TLR5 mediated responses
in lung epithelial cells by inhibition of the forward signal-
ing to IL-8 induction, not by increase of negative feedback
inhibitors. Remarkably however Flagellin-induced A20 ex-
pression appeared importantly higher in the case of the
W74A mutant compared to WT IRAK-M, while IL-1β in-
duced A20 expression appeared reduced for the R97 and
R97/Y105 mutants (Additional file 1: Figure S5).
Discussion
This report represents the first detailed structure function
analysis of the death domain (DD) of human IRAK-M.
Despite the fact that IRAK-M acts as an inhibitor of
inflammation, IRAK-M paradoxically stimulates both NF-
κB and transcription of inflammatory mediators [1,13].
Part of the anti-inflammatory effect of IRAK-M lies in the
capacity of the molecule to deviate the pro-inflammatory
NF-κB signals produced by IRAK-4 via IRAK-1 and
IRAK-2 to a more anti-inflammatory IRAK-4/IRAK-M/
MEKK3 NF-κB signal [13]. Zhou and coworkers convin-
cingly displayed this IRAK-M transmitted NF-κB activity
in the murine system using IRAK-1/IRAK-2 double defi-
cient cells and IRAK-1/IRAK-2/IRAK-M triple deficient
cells derived from knockout mice [13]. In the human
system IRAK-1/IRAK-2 double deficient cells are not
available and we used the well-described capacity [1] of
IRAK-M to drive NF-κB activation spontaneously when
transfected in 293T cells as a model system to study the
NF-κB activating activity of human IRAK-M in cells of
human origin. By mutation of predicted interactive sites,
identified by homology modeling techniques, we demon-
strated the involvement of at least 3 areas on the IRAK-M
DD in the endogenous capacity of IRAK-M to spontan-
eously activate NF-κB, and to induce A20 transcription
and IL-8 expression upon overexpression in 293T cells
(Figure 2). A synopsis of our results is depicted in
Figure 7A with a spacefilling model of the IRAK-M DD
attached to a schematic KD and CTD. Consistent with the
findings of Zhou et al. [13] with murine IRAK-M we
observed that W74 is pivotal for the NF-κB activating
activity by IRAK-M, as well as the surrounding F18 and
Q78. In addition we found that R97 and Y105, located on
the other side of the DD, can be of major importance for a
large part of the NF-κB activating activity of IRAK-M. In
Figure 7A the importance of the DD residues in the en-









































































































































































































































































































































Figure 6 (See legend on next page.)
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Figure 6 Effect of human IRAK-M and death domain mutants in lung epithelial cells. WT IRAK-M and DD-mutants were stably expressed in
the lung epithelial cell line H292 by lentiviral transduction and FACS-sorting of EGFP positive cells which is bicistronically expressed. (A) IRAK-M
expression evaluated by western blotting. (B) The effect of stable IRAK-M expression and IRAK-M mutants was determined on IL-1β and Flagellin
(TLR5) mediated IL-8 expression in the supernatant after 6 hour stimulation. Shaded bars depict results of IRAK-M molecules with combinations of
mutated residues/stretches within the same area. N=8, mean±SEM. * indicates difference with WT IRAK-M P<0.05. (C) Effect of stable expression
of WT and DD domain mutants on IL-8 mRNA levels induced by Flagellin after 3 hours. N=3, mean±SEM.
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http://www.biosignaling.com/content/12/1/77from red (important) to white (not important) based on
the functional analysis of mutants which involved alter-
ations of only 1 or 2–3 consecutive residues. In the pre-
dicted interactive area located between W74 and R97, both
the D19N-L20A-P21A mutant as well as the P22A-A23S
mutant had a partial effect on NF-κB expression. However,
the combined D19-A23 mutant regained its full NF-κB ac-
tivating activity, which indicates that the D19-A23 stretch
is dispensable for NF-κB by IRAK-M and rather has a
regulatory role. IL-8 transcription and protein expression
induced by IRAK-M overexpression in 293T cells can be
uncoupled by mutation of IRAK-M DD residue R97. This
infers that the pathway activated by the R97 interface is
completely different from the pathway activated by the
W74 interface which is we found to be absolutely essential
to both IL-8 transcription and expression in this 293T
model. Consistent with the latter observation, protein dock-
ing experiments suggested that R97 is located on the oppos-
ite side of the putative IRAK-M tetramer, at a site that is
predicted to bind only to the side of the IRAK-4 tetramer
that binds to MyD88 in an experimentally determined myd-
dosome structure (Figure 4). Interaction to IRAK-2 tetra-
mers was predicted only for the binding interface involving
W74 of the IRAK-M-DD tetramer and the free side of
IRAK-2 tetramer in the myddosome. The potential interac-
tions in the cell of IRAK-M with IRAK-4 and IRAK-2 based
on these predictions are schematically depicted in Figure 7B.
It should be mentioned that we modeled the interactions
of IRAK-M with other IRAK family members as if IRAK-M
forms homotetramers and interacts as such with homotetra-
mers of IRAK-4 and IRAK-2. This is based on the experi-
mentally verified homotetramer formation observed for the
isolated death domains of MyD88/IRAK-4/IRAK-2 when
co-crystallized [3]. Full-length proteins may however interact
differently, for instance the intermediate domain that ex-
tends immediately from the DD’s of MyD88 and IRAK-1 are
extremely important for function [24,25]. Also in this regard
we show here that the C-terminal domain of IRAK-M is
functional and contains an active TRAF6 binding site
(Figure 3).
With respect to structure-based predictions the results
with the R70Q IRAK-M mutant are of major importance.
As may be inferred from protein docking experiments, the
R70Q mutant tetramers may form an extra hydrogen
bond with R54 of IRAK-4 tetramers, but loose the R70
interaction points with IRAK-2. In line with its increasedIRAK-4 interaction, the R70Q mutant displayed hyper-
activity towards IL-8 transcription compared to WT when
overexpressed in 293T cells. IL-8 transcription in this
in vitro setting is primarily W74 driven and indeed the
IRAK-4 interaction predicted to be enforced by the R70Q
variant involves the W74 interface. Also IL-8 protein
expression was increased in 293T in case of the R70Q
mutant. Translation induced by IRAK-M in 293T cells ap-
pears primarily R97 driven, presumably through a MyD88
type of interaction of IRAK-M with IRAK-4, which may
drive IRAK-2 activity to translation of inflammatory genes
[13] as depicted in Figure 7B. However, this potential
IRAK-2 translational activity induced by IRAK-M will be,
as in the myddosome, also open for inhibition by
IRAK-M. The predicted loss of an interaction site of
the IRAK-M R70Q mutant with IRAK-2 will relieve this
IRAK-2 inhibition which contributes to the observed
increased IL-8 protein expression. The observations of a
“gain of function” mutant in this regard confirm the qual-
ity and predictive power of our IRAK-M-DD model.
To display an altered anti-inflammatory capacity of the
IRAK-M DD mutants we introduced them in THP-1 mac-
rophages and H292 lung epithelial cells. Zhou et al. [13]
showed that W74 is involved in IRAK-4 binding and NF-
κB activating activity of IRAK-M when macrophages are
stimulated with a viral type TLR7 agonist. Here we show
that W74 is dominantly involved in the capacity of IRAK-
M to reduce TLR2 and TLR4 mediated cytokine release in
macrophages. To our knowledge this is the first demon-
stration that W74 is involved in the inhibitory actions of
IRAK-M. Also surrounding residues of W74 (F18/Q78,
D19-P21, P22-A23, R70) displayed major contributions to
the capacity of IRAK-M to inhibit TNF and IL-6 produc-
tion by Pam3CSK4 and LPS in macrophages. However, the
D19-A23 mutant remained able to reduce LPS induced
TNF and IL-6 production, which is in line with the domin-
ant role of W74 in this feature and an active mode of ac-
tion of IRAK-M as proposed by Zhou et al. [13]. Mutation
of R97 and Y105 in helix 6 had little effect on the capacity
of IRAK-M to inhibit TLR2/4 stimulated TNF production
in macrophages, but did exert a major drop in the potency
of IRAK-M to inhibit LPS stimulated IL-6 production.
Thus, the involvement of residues R97/Y105 of IRAK-M to
inhibit cytokine produced in macrophages is dependent on
the trigger and cytokine evaluated. Analogously, TNF and
IL-6 expression are differentially regulated, with TNF being
Figure 7 Schematic representation of the structure-function relationships of IRAK-M based on this study. (A) Functional involvement of
the different residues of the Death Domain (DD) of IRAK-M on induction of NF-κB, transcription and translation upon overexpression in 293T cells
(data derived from Figures 2 and 3). Graded color code (red->pink->white) indicates the impact of the single mutants on NF-κB in 293T cells
(from red important to white no effect). The stretch D19-A23 is not indicated to be essential to NF-κB because mutation of the complete stretch
(combined D19-P21 and P22-A23 mutation) results in a mutant with normal NF-κB. (B) Schematic representation of the working mechanism of
IRAK-M as inhibitor of MyD88 signaling adapted from Zhou et al. [13], in which IRAK-4/IRAK-M interaction induces transcription of other inhibitors
via MEKK3 dependent NF-κB and in which IRAK-2 mediated mRNA stability and translation is inhibited by IRAK-M. Based on our mutagenesis
studies both W74 as well as R97 in the IRAK-M-DD are pivotal for IRAK-4/IRAK-M mediated NF-κB activity, but R97 is predicted to bind on the
other side of IRAK-4 (see Figure 4). This may induce oligomerization of IRAK-4 and IRAK-1 or IRAK-2 activation, or, since both residues are essential
for the unique, previously shown MEKK3 dependent IRAK-M mediated NF-κB activation, IRAK-4 may be sandwiched by IRAK-M to come to this
pathway as indicated by W74 and R97 interactions. R97 is not predicted to be involved in the interaction of IRAK-M with IRAK-2 for which F18,
D19, P22, R70 and W74 are predicted to be involved.
Du et al. Cell Communication and Signaling 2014, 12:77 Page 13 of 19
http://www.biosignaling.com/content/12/1/77
Du et al. Cell Communication and Signaling 2014, 12:77 Page 14 of 19
http://www.biosignaling.com/content/12/1/77identified as a primary response gene [26]. The observation
that W74 as well as R97 are involved in the inhibition TLR
mediated of IL-6 production indicates an important role for
the R97 type of interaction with IRAK-4 that could either
compete for MyD88 binding to IRAK-4 or provide a special
NF-κB signal to express anti-inflammatory inhibitors.
In contrast to the importance of residues W74 and R97
in aforementioned activities of IRAK-M these residues
were not implicated in the inhibition by IRAK-M of TLR5
mediated IL-8 production by lung epithelial cells
(Figure 6B). Since W74 of IRAK-M is pivotal for IRAK-4
interaction [13] it appears that the functionality of IRAK-
M in the inhibition of TLR5 mediated IL-8 in these epi-
thelial cells is independent of its interaction with IRAK-4.
The R97 mutant displayed even a robust increased inhibi-
tor potency on TLR5 mediated IL-8 production, which
may be related to the reduced IRAK-4 binding possibilities
of this mutant and therefore potentially increased IRAK-2
binding events. Interestingly increased expression of the
inhibitor A20 by IRAK-M as reported [13] was not associ-
ated with the inhibitory effect of IRAK-M in the lung epi-
thelial cell experiments presented here (Additional file 1:
Figure S5). Taken together it appears that the inhibitory
action of IRAK-M on TLR5 mediated IL-8 production in
lung epithelial cells is mainly the result of inhibition of the
functions of IRAK-2. In line, posttranscriptional processes
are reported to dominate TLR5 mediated IL-8 production
in epithelial cells [27] and transcript stabilization and
translation are pathways induced via IRAK-2 [13].
The differential importance of the alternate DD sites of
IRAK-M in their inhibitory functioning under varying con-
ditions is probably due to distinct limiting factors in the in-
volved pathways. Recent discoveries such as the cell specific
regulation of IL-6 production by TLR dependent autophos-
phorylation of IRAK-4 [28] may turn out to be pivotal in
our understanding of IRAK-M as an inhibitor of IRAK-4
dependent processes. It should be stressed that while we
used a theoretical 3D model to rationalize the in vitro ex-
periments, our results show the involvement of the different
residues of IRAK-M at the functional level only. Additional
studies are needed to confirm or refute the potential inter-
actions predicted by our protein modeling studies.
A naturally occurring P22L IRAK-M mutant is reported
to be associated with early onset asthma [19]. Residue P22
is predicted to be involved in IRAK-2/4 and M tetramer in-
teractions (Figure 4 and Additional file 1: Figure S3b). The
enhanced propensity of individuals with the P22L mutation
to develop asthma is in line with the observed decreased
capacity of IRAK-M with mutations in this region (P22A-
A23S mutant) to down-regulate IL-6 expression in macro-
phages upon TLR2/4 stimulation (Figure 5B).
From the overexpression experiment in 293T cells it
could be concluded that residues D19-A21 and P22-A23
are involved in both positive and negative effects onsignaling events. This is consistent with our finding that
the D19-A21 as well as the P22-A23 mutant IRAK-M pro-
teins lack capacity to inhibit cytokine expression in macro-
phages (Figure 5B). This would involve reduced IRAK-4
interaction of IRAK-M at L20, P21, P22 and A23 as well as
reduced IRAK-2 interaction of IRAK-M at D19 and P22.
Interestingly, the relative high NF-κB activity of the D19-
A23 IRAK-M mutant (Figures 2B and 3B) is associated
with low protein levels of this mutant in proficient cells
(Figures 5A and 6A). For IRAK-1 it has been suggested
that an intramolecular interaction of the death domain
with the end of its CTD keeps IRAK-1 in a silent mode be-
fore phosphorylation events trigger its activation [29].
IRAK-1 that lacks the end of its CTD is easily activated
and instable [28]. In the context of IRAK-M one could
hypothesize a role of the D19-A23 stretch in the stability of
IRAK-M either by interaction with its own CTD or specific
interaction/repelling with/of other IRAK or associated
molecules. The lower observed steady state levels of the
IRAK-M mutant protein with the modified D19-A23
stretch (Figures 4A and 5A) would be consistent with
faster turnover through increased kinetics of activation and
subsequent degradation events. In this respect, blotting
experiments with the IRAK-M K526stop mutant that lacks
the C-terminal epitope recognized by the used C-terminal
anti-IRAK-M antibody, showed clearly that both the low
and high molecular bands observed upon expression of
IRAK-M are specific IRAK-M derived products. These
products appear to display the continuous modification
and degradation of WT IRAK-M as well as the mutants
(Figures 2A, 5A, 6A). The phenotype observed with the
K526stop mutant was increased A20 transcription (Fig-
ure 3C) which could support the proposed presence of a
regulatory element in the very C-terminal end of IRAK-M
analogues to the CTD of IRAK-1 [28].
We compared the homologous residues involved in the
function of IRAK-M with those of other IRAK family
members (Additional file 1: Figure S6). The stretch F18-
A23 in IRAK-M, which is involved in NF-κB activating
activity as well as inhibitory activity (Figures 2, 3, 5 and 6),
is least conserved among IRAK proteins (Additional file 1:
Figure S6D). Major difference with IRAK-2 is that A23 in
IRAK-M is a bulky and aromatic tryptophan at the
homologous position in IRAK-2 (W11) (Additional file 1:
Figure S6A and B). Furthermore the negative charge
provided in IRAK-M by D19 is absent in IRAK-2 (Q7). In
IRAK-4 this negative charge is also lacking at the homolo-
gous position (C13), instead a positive charge is provided
in IRAK-4 in this area by R12 in the homologous position
of the aromatic phenylalanine (F18) in IRAK-M (compare
Additional file 1: Figure S6E1 and E3). Undoubtedly these
differences will contribute to the divergent functions of
the different homologous DD. The residues in the D19-
A23 stretch are predicted IRAK-M interaction points with
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A23), and IRAK-2 (D19, P22) (Figure 4).
A rare naturally occurring R97Q IRAK-M mutant has
been reported (rs185025028). Here we show that the R97
binding interface can be of importance for the functioning
of IRAK-M depending on the cell type, stimulus and read-
out. As mentioned, the R97Q mutation has a phenotype
with regard to the functioning of IRAK-M in macrophages
(lower potency to inhibit TLR4 elicited IL-6) and lung epi-
thelial cells (higher potency to inhibit TLR5 elicited IL-8).
It will be interesting to see whether the R97Q genotype is
associated with altered disease phenotype or outcome.
R97 plays an important role in the functioning of IRAK-M
in cooperation with Y105. R97 is conserved in IRAK-2,
but not in IRAK-4. Y105 appears to be unique for IRAK-
M (Additional file 1: Figure S6D), and may be involved in
the specific functionality of IRAK-M. Our protein docking
simulations did not predict an interaction point of Y105
of IRAK-M with the death domains of IRAK-2 or IRAK-4,
we speculate that potentially Y105 is involved in inter-
action of IRAK-M with other mediators such as MEKK3
or IRAK-1.
In conclusion, the present study presents a major
improvement of our knowledge of the structure function
relationships of the DD of IRAK-M. We have provided de-
tailed information on the function of individual regions and
amino acid residues in the IRAK-M DD and present an the-
oretical structural model that may integrate the currently
known structure-function data of IRAK-M. Our findings
may guide and support the targeting of the DD of human
IRAK-M in efforts to generate treatment strategies to boost
the host response in immunocompromised patients.
Methods
Homology modeling and interactive surface prediction
Template selection and alignment
The primary sequence of human IRAK-M consists of 596
amino acids. In order to determine the domain boundaries
of the DD and in order to include the complete domain
region, we applied multiple sequence analysis of IRAK-M
from different species. The death domain could be mod-
eled from C5 to G119 and potential templates for the
IRAK-M DD were selected through PSI-BLAST of the
protein data bank (PDB) [30]. PSI-BLAST (PSSM: 0.005)
resulted in 12 available coordinate files, with sequence
identities between 24% and 30% with the IRAK-M death
domain sequence. Based on sequence alignment score and
structure quality of potential template structures (reso-
lution and R-factor) a final template was selected. We se-
lected 2A9I (DD of mouse IRAK-4), [21] as a template,
based on its sequence identity (28.7%). Moreover, 2A9I is
a high resolution structure of 1.7 Å which was optimized
by the PDB_REDO server with a structural quality of
0.619. The alignment between template and the IRAK-Msequence was performed by ICM-Pro (MolSoft) [31] with
default scoring parameters and refined based on second-
ary structure prediction, amino acid features and the 3D
structure of the template (Figure 1A and Additional file 2:
Table S2).
Backbone generation and loop modeling
For the initial construction of the models we employed
the ICM Pro molecular modeling package Molsoft as
well as LOOPY [32]. ICM-Pro was used to generate the
backbone coordinates for the models, from the refined
sequence alignment between template and query structure,
except in several variable (loop) regions, for which we used
LOOPY. If the template and target had identical residues
also the side chain coordinates could be included. Side
chains were minimized by steepest descent and simulated
annealing minimization with a fixed backbone conform-
ation and next optimized without any restraint using the
ICM Pro package.
MD simulation and quality check
The optimized model structure was further refined using a
short MD simulation in explicit water (density 0.997, pH
7.0) for 500 picoseconds, employing the Yasara-Whatif
twin package. The YAMBER3 force field was used, periodic
boundaries and long range Coulomb interactions were
included with a cutoff of 7.86Å. Every 25 ps, a simulation
snapshot was saved, and in total, 20 snapshots were pro-
duced. Every snapshot and template were submitted for
online structure quality check at http://nihserver.mbi.ucla.
edu/SAVES_3/, using PROCHECK, WHATIF, VERIFY-3D,
ERRAT and PROVE. The snapshot with the best total en-
ergy was selected as the starting point for a 100 ns MD
simulation, with the AMBER03 force field periodic bound-
aries and long range Coulomb interactions were included
with a cutoff of 7.86 Å in explicit water (Density 0.997, pH
7.0). The resulting energies, RMSD, residues' flexibility,
hydrogen bonds and Ramachandran plots from the MD
simulation were calculated.
Evaluation of the structural quality (Additional file 2:
Table S3) of the final death domain model indicated that
92.1% of the residues were located in most favored zones
and the remaining 7.9% were present in allowed regions
as analyzed by inspection of a Ramachandran plot. Con-
formation Z-scores of both the model and the template
were low, though the model’s side chain planarity and
inter atomic distances were good. The structure’s non-
bonding interactions were qualified as good in both the
model and the template. The residue environment in the
model is not better than that in template, but both of
them are qualified as reasonable. A 100 ns MD simulation
was performed to analyze the structural stability, amino
acid fluctuation, and potential energy changes of the
IRAK-M death domain (Additional file 1: Figure S1).
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bond, angle, planarity, coulomb, VdW) was stable while
the conformation of the model changed during the simu-
lation until 10 ns and then stabilized. The fluctuation of
each residue during the MD simulation was calculated,
and we observed that the loop between helix3 and helix4
was flexible. The number of hydrogen bonds, known to be
important for protein stability and function [33], was gen-
erally consistent in the model during the simulation. A107
and N104 form hydrogen bonds with each other and thus
connect helix 6 with the C-terminal loop.
Prediction of protein-protein contacts
A consensus approach was used to predict protein-protein
interactions for the model structure generated by applica-
tion of several structural bioinformatics methods. We
employed: Optimal Docking Area (ODA) [34], Cons-PPISP
[35] and PPI-Pred [36]. For each of these methods, a
prediction score was obtained for all residues in the death
domain of IRAK-M and a consensus was generated from
the different methods applied, taking into account the
accessibility of the residue. Several important residues for
the interaction between the IRAK-4 DD and the DD of
MyD88 have been predicted on basis of an earlier pub-
lished model of the death domain: Q29, E92, F93, F94 at
the surface of helix 2 and helix 5 [37]. Furthermore,
residues which potentially interact with IRAK-1 in the N-
terminus and the end of the helix 4: R12, C13, E69, D73,
T76 were also predicted using PPI-Pred. T66 in the death
domain of IRAK-1 is critical for interaction with signaling
molecules reported by Neumann and coworkers [38]. In
our model of the IRAK-M DD, the following residues in
the homologous positions were found: C35, R47, E59, D63,
T69, Q78, D85, R96, R97 respectively. Taking into account
their flexibility and accessibility (Figure 1B), the residues,
Q78, F18, D19, P21, P22, A23, W74, L20, R70, S75, R97,
Y105, A77, L101, in order of likelihood, were predicted as
potential sites of interaction with IRAK-M ligands.
Combined with residue spatial fluctuations as deter-
mined from MD simulation, hydrogen bond network
analysis and homologue analysis, we proposed the muta-
genesis of selected residues which we hypothesized to be
involved in protein-protein interaction (Figure 1C).
Mutagenesis and expression of human IRAK-M mutants
Human IRAK-M and IRAK-1 mammalian expression vec-
tors (pUNO) containing a blasticidin resistance element
were obtained from Invivogen (Toulouse, France). IRAK-
M mutants were generated by site-directed mutagenesis
with the QuickChange kit (Stratagene, La Jolla, CA) as rec-
ommended by the manufacturer with primers containing
the desired mutations. Creation of an IRAK-M mutant
which lacks the entire death domain was accomplished by
introduction of a second SacII site (aaacta -> ccgcgg) in theORF at codon position 103–105. SacII restriction of this
mutated plasmid releases a fragment by cleavage at the
introduced site and at the endogenous SacII site in codon
7–9 of the ORF. Ligation of the plasmid generates an ORF
that encodes for amino acid 1–9 connected to 105–596
without introduction of additional amino acids. Constructs
were subjected to DNA sequencing to confirm the muta-
tions and check of the appropriate CDS. 293T cells, main-
tained in DMEM containing 10% FCS, were transfected
using Lipofectamine 2000 (Invitrogen) as recommended by
the manufacturer with the plasmids for protein expression
and induction of NF-κB activation and IL-8 release essen-
tially as described [1]. Lentiviral expression was obtained
by introduction of WT IRAK-M in the pHEF vector and
virus production in 293T cells as described [39,40]. The
different IRAK-M Death Domain mutations were intro-
duced in the constructed lentiviral human IRAK-M/IRES-
eGFP expression system by restriction digestion of the
pUNO-IRAK-M mutants with AgeI and BstB1 to obtain
the mutated region which was ligated in the pHEF-IRAK-
M vector which was digested with Xma1 (compatible over-
hang with Age1) and BstB1 to open up and remove the
WT sequence. Non-replicating lentivirus production for
transduction and expression of these mutants in cells was
performed according to standard procedures [39]. Cell
lines were transduced with the generated lentiviral con-
structs by standard procedures [40] with addition of
polybrene. After lentiviral transduction with only eGFP as
control, WT IRAK-M or the mutants, the populations of
cells expressing the transgene were selected by cell sorting
using the GFP signal as described [41].
The monocyte cell line THP-1 and transduced cultures
were maintained in RPMI with 10% FCS and pen/strep.
The bronchial type lung epithelial cell line H292, which
is devoid of IRAK-M transcripts, was maintained as well
as the transduced cultures in IMDM with 10% FCS and
pen/strep.
Western blotting
Westernblotting for IRAK-M was performed with 1 μg/ml
monospecific rabbit anti-human IRAK-M antibodies
directed against the C-terminal (Cell Signaling) or poly-
clonal mouse anti-full length human IRAK-M (Abnova)
essentially as described [20]. B-actin antibodies were from
Cell Signaling.
NF-κB activation
Activation of NF-κB was determined 24 hours after trans-
fection by cotransfection of a Firefly Luciferase NF-κB
driven reporter construct and a Renilla Luciferase CMV
driven construct on cell samples lysed with lysis buffer
supplied with the DualGlo kit (Promega) used to deter-
mine the Firefly and Renilla luciferase activity in the same
sample as recommended by the manufacturer.
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For IL-8 expression by transfected 293T cells, the cells
were washed 24 hours after transfection and fresh culture
medium was placed on the cells and supernatant was har-
vested 24 hours later and stored at −20°C for ELISA.
Transduced H292 cells were plated in 96-wells cell culture
plates (50.000 cells/well) and grown to confluency in 3
days and the medium was refreshed 24 hours before
stimulation. Immediately before stimulation cells were
washed again with medium again and cells were stimu-
lated with 2 ng/ml IL-1β (Miltenyi Biotec) or 25 ng/ml
Flagellin (Invivogen) for 6 hours and supernatant was col-
lected and stored at −20°C for ELISA. IL-8 was deter-
mined using the duoset capture and biotinylated detecting
antibody as recommended by the manufacturer
(Invitrogen).
TNF and IL-6
The monocyte cell line THP-1 and transduced cultures
were maintained in RPMI with 10% FCS and pen/strep
and matured to adherent macrophages and stimulated as
described under conditions that will induce LPS tolerance
after a previous exposure to LPS [42]. Supernatant of ma-
tured THP-1 cells stimulated with 1 ng/ml LPS (ultrapure,
Invivogen) or 500 ng/ml Pam3CSK4 (Invivogen) for 6 hour
was collected and stored at −20°C for determination of
TNF and IL-6 by CBA (BD Biosciences) as described [43].
IL-8, A20, SHIP and SOCS-3 mRNA expression
IL-8 and negative regulators of inflammation were deter-
mined at the mRNA level by RT-qPCR as described [20].
The formation of IRAK-M-DD tetramer and the preparation
of IRAK-4-DD tetramer, IRAK-2-DD tetramer and the
complex of IRAK-2/IRAK-4/MyD88
Four IRAK-M-DD modules were superimposed onto ei-
ther IRAK-2 (3D packing quality: −1.231) or IRAK-4 (3D
packing quality: −1.241) DD tetramers respectively in
the crystallographic model (3MOP, [3] by utilizing ICM-
Pro Molsoft. The coordinates of four superimposed
IRAK-M-DD were merged into one coordinate file of an
IRAK-M-DD tetramer. The two obtained IRAK-M-DD
tetramers were highly similar (Additional file 1: Figure
S3A) with an all atom RMSD value of 1.05 Å. With the
slightly higher 3D packing quality we used the IRAK-2-DD
derived tetramer for further protein-protein docking
studies. We first analyzed the atomic interactions (con-
tact distance <=4 Å) between the individual IRAK-M
monomers in the IRAK-M-DD tetramer (Additional file 1:
Figure S3B). Next, IRAK-4 tetramer, IRAK-2 tetramers
and IRAK-2/IRAK-4/MyD88 complex were retrieved from
the crystallographic model 3MOP, with all hydrogen
atoms added according to the protonation state at pH=7,
which means that all acidic residues (Asp and Glu) aredeprotonated and all basic residues (Lys and Arg) are
protonated.
Protein-protein docking
Hex protein docking [44] was applied to dock the IRAK-
M-DD tetramer to IRAK-4-DD tetramer, IRAK-2-DD
tetramer and IRAK-2/IRAK-4/MyD88 complex respect-
ively. We analyzed 100 docking events for IRAK-4-DD
tetramer binding to IRAK-M-DD and found that 63% of
the docked poses were to the W74 exposing side of the
IRAK-M-DD tetramer and 37% to the R97 exposing side
of the IRAK-4-DD tetramer. The IRAK-M/IRAK4-DD
complex was then docked with another IRAK-M-DD
tetramer and the docked results showed that the sandwich
IRAK-M/IRAK-4/IRAK-M complex was formed, where
the W74 exposing site of IRAK-M tetramer docked with
the bottom surface (IRAK-2 tetramer binding surface in
3MOP) of IRAK-4 tetramer and the R97 exposing site of
IRAK-M tetramer docked with the top surface (MyD88
binding surface in 3MOP) of IRAK-4 tetramer.
Docking of the IRAK-M-DD tetramer to the IRAK-2-DD
tetramer indicated that in a vast majority (83%) this would
lead to a W74 exposing side (IRAK-M-DD tetramer) inter-
action and only in 17% in an interaction with the R97 ex-
posing side. The IRAK-M-DD tetramer was docked to the
bottom surface of the IRAK-2-DD tetramer from the
IRAK-2/IRAK-4/MyD88 complex (Additional file 1: Figure
S4F). The atomic interactions (contact distance <=4 Å) be-
tween IRAK-M-DD tetramer and the 3MOP structure
were analyzed (Additional file 1: Figure S4E).
Statistical analyses
Differences between WT and mutant protein were calcu-
lated by Mann–Whitney U test. Values are expressed as
mean ± SEM. A p<0.05 was considered to represent a
statistical significant difference.
Additional files
Additional file 1: Figure S1. Analysis of 100 ns molecular dynamics
(MD) simulation of hIRAK-M-DD model. Figure S2. Western blots on
IRAK signaling proteins on lysates of 293T cells transfected with WT
IRAK-M and mutants. No major differences were observed. Figure S3.
(A) Superposition of the IRAK-M-DD tetramers modelled on the structure
of the IRAK2-DD tetramer in 3MOP (gray) and IRAK-4-DD tetramer in
3MOP (Red). The 3D structure of those tetramers were highly similar and
the all atom backbone root mean standard deviation (RMSD) between
them was 1.05 Å. (B) IRAK-M-DD interaction points predicted to be
important for homomeric tetramer formation based on the crystallographic
model of human MyD88/IRAK-4/IRAK-2 complex (3MOP). The binding sites
of one IRAK-M momomer (purple) to two other IRAK-M monomers (yellow
and grey) in the IRAK-M tetramer. Figure S4. Stable expression of R70Q and
D19N-A23S mutants in H292 cells as evaluated at the mRNA level by
RT-qPCR. Figure S5. Effect of over expression of the different IRAK-M
death domain mutants in H292 cells on the expression of other negative
regulators. Figure S6. Comparison of the hIRAK-M Death Domain
interactive surface with IRAK-2 and IRAK-4 DD’s.
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mutations on structural stability. Table S2. The structural quality of the
template (2A9I from PDB_REDO Joosten RP, Acta Cryst. 2012) used to build
human IRAK_M model. Table S3. Quality check of IRAK-M-DD model and
the template by programs PROCHECK, WHATIF, VERIFY-3D, ERRAT and
PROVE.
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